Interleukin-1 (IL-1) is a potent regulator of cardiovascular proliferation, apoptosis, contraction or production of inflammatory mediators. Thus, we investigated expression and function of IL-1 in cultured neonatal rat heart cells upon endotoxin stimulation. We show that cultured neonatal rat cardiomyocytes expressed IL—1α and IL—1β mRNA. The cells expressed functional cell-associated IL—1 activity and a specific anti-IL—1α-antibody inhibited the activity. Biologically active IL—1α was present at the cell surface of the cardiomyocytes, as indicated in co-culture experiments. Immunohistochemistry showed IL—1α-staining of the neonatal cardiomyocytes. Although the cells also expressed IL—1β mRNA, we did not detect IL—1β in the supernatants of cultured cardiomyocytes by ELISA or in immunohistochemical staining. Furthermore, neonatal and adult rat heart tissues expressed IL—1α mRNA, whereas fetal, but not adult, human cardiac tissues expressed detectable IL—1α mRNA. In contrast, IL-1β mRNA was present in rat and human fetal and adult samples. Furthermore, in patients with dilated or ischemic cardiomyopathy, we measured IL—1β, but not IL—1α, mRNA. These results provide evidence for the presence of functionally active IL—1α on the cell surface of neonatal rat cardiomyocytes and may suggest a differential role of IL—1α in regulation of cellular functions during development, aging and disease in rat and human heart cells.
Dinarello CABiologic basis for interleukin-1 in disease . Blood1996; 87: 2095—2147.
2.
Loppnow H., Werdan K., Reuter G., Flad H-D.The interleukin-1 and interleukin-1-converting enzyme families in the cardiovascular system. Eur Cytokine Netw1998; 9: 675—680.
3.
Dinarello CA , Pomerantz BJProinflammatory cytokines in heart disease . Blood Purif2001; 19: 314—321.
4.
Chamberlain J., Evans D., King A. et al. Interleukin-1β and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice. Am J Pathol2006; 168: 1396—1403.
5.
Müller-Werdan U., Schumann H., Loppnow H. et al. Endotoxin and tumor necrosis factor-α exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. J Mol Cell Cardiol1998; 30: 1027—1036.
6.
Devaux B., Scholz D., Hirche A., Klövekorn WP, Schaper J.Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J1997; 18: 470—479.
7.
Bick RJ, Liao JP, King TW, LeMaistre A., McMillin JB, Buja LMTemporal effects of cytokines on neonatal cardiac myocyte Ca++ transients and adenylate cyclase activity. Am J Physiol1997; 41: H1937—H1944.
8.
Thaik CM, Calderone A., Takahashi N., Colucci WSInterleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest1995; 96: 1093—1099.
9.
Ing DJ, Zang J., Dzau VJ, Webster KA, Bishopric NHModulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res1999; 84: 21—33.
10.
Beasley D., Cohen RA, Levinsky NGInterleukin-1 inhibits contraction of vascular smooth muscle. J Clin Invest1989; 83: 331—335.
11.
Hosenpud JD , Campbell SM, Mendelson DJInterleukin-1-induced myocardial depression in an isolated beating heart preparation. J Heart Transplant1989; 8: 460—464.
12.
Cain BS, Meldrum DR, Dinarello CA et al. TNF and IL-1 synergistically depress human myocardial function . Crit Care Med1999; 27: 1309—1318.
13.
Stein B., Frank P., Schmitz W., Scholz H., Thoenes M.Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol1996; 28: 1631—1639.
14.
Ono K., Matsumori A., Shioi T., Furukawa Y., Sasayama S.Cytokine gene expression after myocardial infarction in rat hearts. Possible implication in left ventricular remodeling. Circulation1998; 98: 149—156.
15.
Shioi T., Matsumori A., Sasayama S.Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation1996; 94: 2930—2937.
16.
Freeman GL, Colston JT, Zabalgoitia M., Chandrasekar B.Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis. Am J Physiol1998; 274: H249—H258.
17.
Shioi T., Matsumori A., Kihara Y. et al. Increased expression of interleukin-1β and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res1997; 81: 664—771.
18.
Chandrasekar B., Melby PC, Troyer DA, Colston JT, Freeman GLTemporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy . Am J Pathol1998; 152: 925—934.
19.
Han RO, Ray PE, Baughman KL, Feldman AMDetection of interleukin and interleukin-receptor mRNA in human heart by polymerase chain reaction. Biochem Biophys Res Commun1991; 181: 520—523.
20.
Francis SE, Holden H., Holt CM, Duff GWInterleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol1998; 30: 215—223.
21.
Satoh M., Tamura G., Segawa I., Tashiro A., Hiramori K., Satodate R.Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy . Virchows Arch1996; 427: 503—509.
22.
Long CSThe role of interleukin-1 in the failing heart. Heart Fail Rev2001; 6: 81—94.
23.
Schmidtke M. , Glück B., Merkle I., Hofmann P., Stelzner A., Gemsa D.Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis . J Med Virol2000; 61: 518—526.
24.
Okuno M., Nakagawa M., Shimada M., Saito M., Hishinuma S., Yamauchi-Takihara K.Expressional patterns of cytokines in a murine model of acute myocarditis: early expression of cardiotrophin-1. Lab Invest2000; 80: 433—440.
25.
Werdan K., Erdmann E.Preparation and culture of embryonic and neonatal heart muscle cells: modification of transport activity. Methods Enzymol1989 ; 173: 634—662.
26.
Ross R., Kariya B.Morphogenesis of vascular smooth muscle in atherosclerosis and cell structure . In: Bohr DF, Somlyo AP, Sparks HY. (eds) Handbook of Physiology, The Cardiovascular System, Section 2 . Bethesda, MD: American Physiological Society, 1980; 66—91..
27.
Loppnow H., Libby P.Proliferating or interleukin-1-activated human vascular smooth muscle cells secrete copious interleukin-6. J Clin Invest1990; 85: 731—738.
28.
Loppnow H., Bil R., Hirt S. et al. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood1998; 91: 134—141.
29.
Loppnow H., Flad H-D., Dürrbaum I. et al. Detection of interleukin-1 with human dermal fibroblasts. Immunobiology1989; 179: 283—291.
30.
Loppnow H., Libby P.Functional significance of human vascular smooth muscle cell-derived interleukin-1 in paracrine and autocrine regulation pathways. Exp Cell Res1992; 198: 283—290.
31.
Van Snick J. , Cayphas S., Vink A. et al. Purification and NH2terminal amino acid sequence of a T-cell derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA1986; 83: 9679—9683.
32.
Chomczynski P., Sacchi N.Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem1987; 162: 156—159.
33.
Seta Y., Shan K., Bozkurt B., Oral H., Mann DLBasic mechanisms in heart failure: the cytokine hypothesis. J Card Fail1996; 2: 243—249.
34.
Werdan K.The activated immune system in congestive heart failure — from dropsy to the cytokine paradigm. J Intern Med1998 ; 243: 87—92.
35.
Paulus WJHow are cytokines activated in heart failure? Eur J Heart Fail1999; 1: 309—312.
36.
Hansson GK, Libby P.The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol2006; 6: 508—519.
37.
Clinton SK, Fleet JC, Loppnow H. et al. Interleukin-1 gene expression in rabbit tissue in vivo. Am J Pathol1991; 158: 1005—1014.
38.
Isoda K., Kamezawa Y., Tada N., Sato M., Ohsuzu F.Myocardial hypertrophy in transgenic mice overexpressing human interleukin-1α . J Card Fail2001; 7: 355—364.
39.
Nicklin Mjh , Hughes DE, Barton JL, Ure JM, Duff GWArterial inflammation in mice lacking the interleukin-1 receptor antagonist gene. J Exp Med2000; 191: 303—311.
40.
Horai R., Asano M., Sudo K. et al. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion . J Exp Med1998; 187: 1463—1475.
41.
Merhi-Soussi F., Kwak BR, Magne D. et al. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res2005; 66: 583—593.
42.
Francis SE, Camp NJ, Dewberry RM et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation1999; 99: 861—866.
43.
Manzoli A., Andreotti F., Varlotta C. et al. Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease . Cardiologia1999; 44: 825—830.
44.
Momiyama Y. , Hirano R., Taniguchi H., Nakamura H., Ohsuzu F.Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol2001; 38: 712—717.
45.
Brody JI, Pickering NJ, Capuzzi DM, Fink GB, Can CA, Gomez F.Interleukin-1α as a factor in occlusive vascular disease. Am J Clin Pathol1992; 97: 8—13.
46.
Wang CY, Naka Y., Liao H. et al. Cardiac graft intercellular adhesion molecule-1 (ICAM-1) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-1 in organs remote from the site of transplantation. Circ Res1998; 82: 762—772.
47.
Nakagawa M. , Terracio L., Carver W., Birkedal-Hansen H., Borg TKExpression of collagenase and IL-1 α in developing rat hearts. Dev Dyn1992; 195: 87—99.
48.
Galea J., Armstrong J., Gadsdon P., Holden H., Francis SE, Holt CMInterleukin-1β in coronary arteries of patients with ischemic heart disease . Arterioscler Thromb Vasc Biol1996; 16: 1000—1006.
49.
Van Hoffen E , Van Wichen D, Stuij I. et al. In situ expression of cytokines in human heart allografts. Am J Pathol1996 ; 149: 1991—2003.
50.
Petersen CA , Krumholz KA, Burleigh BAToll-like receptor 2 regulates interleukin-1β-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi. Infect Immun2005; 73: 6974—6980.
Maier JA, Statuto M., Ragnotti G.Endogenous interleukin- 1α must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol1994; 14: 1845—1851.
53.
Kurt-Jones EA, Beller DI, Mizel SB, Unanue ERIdentification of a membrane-associated interleukin-1 in macrophages. Proc Natl Acad Sci USA1985 ; 82: 1204—1208.
54.
Kaplanski G. , Farnarier C., Kaplanski S. et al. Interleukin-1 induces IL-8 secretion from endothelial cells by a juxtacrine mechanism. Blood1994; 84: 4242—4248.
55.
Fuhlbrigge RC, Fine SM, Unanue ER, Chaplin DDExpression of membrane interleukin-1 by fibroblasts transfected with murine pro-interleukin-1α cDNA. Proc Natl Acad Sci USA1988; 85: 5649—5653.
